The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times BPC 157: Miracle Healing Peptide or Hidden Danger?